Bio-Rad Laboratories Inc.
BIO | NYSE
$373.19
+$1.01 (+0.27%)
Nov 2, 2026, 9:53 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 531.8M | 488.1M | 403.8M | 434.22M | 470.78M | 662.21M |
Short-Term Investments | 1.01B | 1.18B | 1.2B | 1.36B | 399.14M | 328.91M |
Long-Term Investments | 6.1B | 4.84B | 7.7B | 8.83B | 14.39B | 9.56B |
Other Long-Term Assets | 102.3M | 101.9M | 94.9M | 94.6M | 104.19M | 86.72M |
Receivables | 472.5M | 452.5M | 489M | 494.65M | 423.54M | 419.42M |
Inventory | 740.7M | 760M | 780.5M | 719.32M | 572.24M | 622.25M |
Other Current Assets | 13.8M | 30.7M | 31.7M | 29.16M | 15.65M | 16.42M |
Total Current Assets | 2.91B | 3.03B | 3.05B | 3.16B | 1.99B | 2.14B |
Property-Plant & Equipment | 709.9M | 688.6M | 723.7M | 679.55M | 716.44M | 693.51M |
Goodwill & Intangibles | 754.1M | 704.1M | 734.1M | 738.6M | 601.2M | 491.4M |
Total Long-Term Assets | 7.67B | 6.33B | 9.25B | 10.34B | 15.81B | 10.83B |
Total Assets | 10.58B | 9.36B | 12.3B | 13.5B | 17.8B | 12.97B |
Account Payables | 129M | 122.3M | 144.6M | 135.04M | 141.94M | 139.45M |
Deferred Revenue | n/a | n/a | n/a | 52.21M | 50.85M | 42.47M |
Short-Term Debt | 37.9M | 1.2M | 500K | 465K | 489K | 1.3M |
Other Current Liabilities | 141.2M | 147.2M | 161.6M | 117.44M | 127.94M | 131.1M |
Total Current Liabilities | 517M | 467.8M | 522.8M | 568.71M | 680.94M | 631.54M |
Long-Term Debt | 1.34B | 1.2B | 1.2B | 1.2B | 10.51M | 1.3M |
Other Long-Term Liabilities | 53.4M | 177.2M | 195M | 195.93M | 182.19M | 196.93M |
Total Long-Term Liabilities | 2.61B | 2.33B | 3.04B | 3.32B | 3.43B | 2.46B |
Total Liabilities | 3.12B | 2.79B | 3.56B | 3.89B | 4.11B | 3.09B |
Total Debt | 1.53B | 1.37B | 1.41B | 1.39B | 223.38M | 225.74M |
Book Value | 7.45B | 6.57B | 8.74B | 9.62B | 13.69B | 9.88B |
Book Value Per Share | 273.22 | 232.84 | 299.26 | 322.82 | 453.03 | 327.58 |
Common Stock | n/a | n/a | n/a | 3K | 3K | 3K |
Retained Earnings | 8.18B | 7.42B | 9.26B | 9.9B | 13.53B | 9.27B |
Comprehensive Income | -189.1M | -538.2M | -336M | -466.82M | -175.55M | 282.46M |
Shareholders Equity | 7.45B | 6.57B | 8.74B | 9.62B | 13.69B | 9.88B |
Total Investments | 7.11B | 6.02B | 8.9B | 10.19B | 14.79B | 9.89B |
Add to Watchlist
Select watchlists to add or remove BIO